Dioxin health risk to infants using simulated tissue concentrations

Wakae Maruyama1, Kikuo Yoshida, Yasunobu Aoki

  • 1Research Center for Environmental Risk, National Institute for Environmental Studies,16-2 Onogawa, Tsukuba 305-8506, Japan.

Insights

Physiologically based pharmacokinetic (PBPK) models simulated dioxin levels in infants. Breast-fed infants had higher liver dioxin concentrations, indicating potential risks requiring further study.

Area of Science:

  • Environmental Health
  • Toxicology
  • Pharmacokinetics

Background:

  • Dioxin exposure in infants and children is a public health concern.
  • Understanding dioxin pharmacokinetics is crucial for risk assessment.

Purpose of the Study:

  • To simulate dioxin concentrations in infant and child populations using PBPK models.
  • To assess potential health risks associated with dioxin exposure in infants.

Main Methods:

  • Development and validation of PBPK models for infant and child populations.
  • Simulation of temporal dioxin concentration patterns in various tissues.
  • Calculation of toxic equivalency (TEQ) for dioxin mixtures in the liver.

Main Results:

  • PBPK infant model showed good agreement with literature data.
  • Simulated maximum liver concentrations were 16.8 pg TEQ/g in breast-fed and 3.5 pg TEQ/g in formula-fed infants.
  • Breast-fed infant liver concentrations were significantly lower than levels associated with adverse health effects in animal models.

Conclusions:

  • Current dioxin contamination levels may pose risks to infants.
  • Further dose-response data is needed for a comprehensive quantitative risk assessment.

Related Concept Videos

Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...